Cephalexin
Cephalexin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Respiratory tract infections S. pneumoniae and S. pyogenes
- Author’s comment: generally not recommended, certainly empirically.
- Otitis media caused by S. pneumoniae, H. influenzae, S. aureus (MSSA), S. pyogenes, and M. catarrhalis
- Skin and skin-structure infections caused by S. pyogenes and S. aureus (MSSA)
- Osteomyelitis: MSSA and/or P. mirabilis
- Author’s comment: not a first-line agent.
- Urinary tract infections including acute prostatitis caused by E. coli, P. mirabilis, and K. pneumoniae
- Author’s comment: not a first-line agent
NON-FDA APPROVED USES
NON-FDA APPROVED USES
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
INDICATIONS
FDA
FDA
- Respiratory tract infections S. pneumoniae and S. pyogenes
- Author’s comment: generally not recommended, certainly empirically.
- Otitis media caused by S. pneumoniae, H. influenzae, S. aureus (MSSA), S. pyogenes, and M. catarrhalis
- Skin and skin-structure infections caused by S. pyogenes and S. aureus (MSSA)
- Osteomyelitis: MSSA and/or P. mirabilis
- Author’s comment: not a first-line agent.
- Urinary tract infections including acute prostatitis caused by E. coli, P. mirabilis, and K. pneumoniae
- Author’s comment: not a first-line agent
NON-FDA APPROVED USES
NON-FDA APPROVED USES
There's more to see -- the rest of this entry is available only to subscribers.